GlycoMimetics (NASDAQ:GLYC) Now Covered by StockNews.com
Research analysts at StockNews.com started coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Free Report) in a research note issued on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. GlycoMimetics Stock Performance NASDAQ GLYC opened at $0.27 on Thursday. GlycoMimetics has a fifty-two week low of $0.14 and a fifty-two week […]
